Posted by Michael Wonder on 15 Feb 2023
FDA gene therapy head raises concern on accelerated approval use
14 February 2023 - More than 1,000 cell and gene therapy clinical trials registered.
More cell and gene therapies will likely come to market using FDA’s accelerated approval pathway, a shift that raises concerns for the agency’s outgoing gene therapy head since it could take a while to prove definitively that they work.
